{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:55:08Z","timestamp":1793156108460,"version":"4.5.0"},"reference-count":10,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DD&amp;T"],"published-print":{"date-parts":[[2025,6,30]]},"DOI":"10.5582\/ddt.2025.01055","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T22:07:26Z","timestamp":1751062046000},"page":"208-209","source":"Crossref","is-referenced-by-count":44,"title":["The pTau217\/A\u03b2&lt;sub&gt;1-42&lt;\/sub&gt; plasma ratio: The first FDA-cleared blood biomarker test for diagnosis of Alzheimer's disease"],"prefix":"10.5582","volume":"19","author":[{"given":"Shasha","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haizhou","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Weihai Central Hospital Affiliated to Qingdao University, Weihai, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, Shandong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, Cummings J, van der Flier WM. Alzheimer&apos;s disease. Lancet. 2021; 397:1577-1590.","DOI":"10.1016\/S0140-6736(20)32205-4"},{"key":"2","unstructured":"2. World Health Organization. World failing to address dementia challenge. <i>https:\/\/www.who.int\/news\/item\/02-09-2021-world-failing-to-address-dementia-challenge<\/i> (accessed June 1, 2025). ."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Lu DR, Dou FZ, Gao JJ. Development of amyloid beta-directed antibodies against Alzheimer&apos;s disease: Twists and turns. Drug Discov Ther. 2023; 17:440-444.","DOI":"10.5582\/ddt.2023.01215"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Ma YN, Wang ZJ, Tang W. Deep cervical lymphaticovenous anastomosis in Alzheimer&apos;s disease: A promising frontier or premature enthusiasm? BioSci Trends. 2025; 19:144-149.","DOI":"10.5582\/bst.2025.01108"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Gu XL, Qi L, Qi Q, Zhou J, Chen S, Wang L. Monoclonal antibody therapy for Alzheimer&apos;s disease focusing on intracerebral targets. BioSci Trends. 2024; 18:49-65.","DOI":"10.5582\/bst.2023.01288"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ma YN, Xia Y, Karako K, Song PP, Tang W, Hu XQ. Serum proteomics reveals early biomarkers of Alzheimer&apos;s disease: The dual role of APOE-\u03b54. BioSci Trends. 2025; 19:1-9.","DOI":"10.5582\/bst.2024.01365"},{"key":"7","unstructured":"7. US Food and Drug Administration. FDA Clears First Blood Test Used in Diagnosing Alzheimer&apos;s Disease. <i>https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-clears-first-blood-test-used-diagnosing-alzheimers-disease<\/i> (accessed June 5, 2025)."},{"key":"8","unstructured":"8. Sysmex. Early Detection of Alzheimer&apos;s Disease with a Simple Blood Test. <i>https:\/\/www.sysmex-europe.com\/products\/diagnostics\/immunochemistry\/alzheimer-disease\/<\/i> (accessed June 7, 2025)."},{"key":"9","unstructured":"9. C2N Diagnostics. C2N Diagnostics&apos; PrecivityAD2\u2122 Blood Test Receives MHRA Medical Device Certification in the United Kingdom. <i>https:\/\/c2n.com\/news-releases\/c2n-diagnostics-precivityad2-blood-test-receives-mhra-medical-device-certification-in-the-united-kingdomnbsp<\/i> (accessed June 10, 2025)."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Palmqvist S, Tideman P, Mattsson-Carlgren N, <i>et al<\/i>. Blood biomarkers to detect Alzheimer disease in primary care and secondary care. JAMA. 2024; 332:1245-1257.","DOI":"10.1001\/jama.2024.13855"}],"container-title":["Drug Discoveries &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/19\/3\/19_2025.01055\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T04:49:19Z","timestamp":1751690959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/19\/3\/19_2025.01055\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5582\/ddt.2025.01055","relation":{},"ISSN":["1881-7831","1881-784X"],"issn-type":[{"value":"1881-7831","type":"print"},{"value":"1881-784X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"article-number":"2025.01055"}}